Drug Discovery Platform/PAMAP

Overview of Services (April 2024)

The Former Drug Discovery Platform (DDP) is now part of the new Proteomics and Molecular Analysis Platform (PAMAP).  We are providing structure-based drug design

and synthetic support to the Research Institute of the McGill University Health Centre

researchers. With our drug discovery expertise and state-of-the-art analytical instrument

facilities (NMR, LC-MS, and MALDI IMS), we identify and validate promising new biological and chemical entities (including

biomarkers) for life-threatening diseases.

Leadership

 The Proteomics Molecular Analysis Platform is staffed by specialists with extensive experience in proteomics, lipidomics and targeted molecular assays and provide the most up-to-date analysis services and technologies.

• Director: Dr. Jean-François Trempe

• Manager: Lorne Taylor

• Research Assistants: Amy Wong, Jenna Cleyle, Jennifer Nedow

• Mass Spectrometry Specialists: Ari Gritsas, Anne-Laure Larroque

Location and hours of operation

Links and Resource

[ Website ]

Contacts